A biochip is a bio-microarray gadget utilized for the examination of huge scope genomics, proteomics, and useful genomics. It discovers application in clinical exploration, diagnostics, drug advancement, toxicology studies, and patient choice for clinical preliminaries.
The U.S. biochip products and services market was valued at US$ 5,161.8 Mn in 2020 and is forecast to reach a value of US$ 11,151.8 Mn by 2027 at a CAGR of 10.1% between 2021 and 2028. Increasing product approvals and launches during the forecast period.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/3899
Drivers:
The approval and launch of new products are expected to drive the growth of the US biochip products and services market over the forecast period. AYOXXA Biosystems GmbH, for example, launched LUNARISTM Chemokine Kits in April 2019 to investigate human (Human 11-Plex) and murine (Mouse-12-Plex) chemokine signaling pathways.
Opportunities:
Research and Development in biochips are expected to offer worthwhile development openings for major parts of the U.S. biochip products &service market. For example, in May 2020, specialists from the Russian Academy of Sciences, Russia, announced the advancement of 3D biochips and enhanced scientific strategies that can encourage further examinations towards viable application for hepatitis C infection discovery.
Restraints:
Accessibility of elective innovations, for example, mass spectrometry and polymerase bind response are expected to restrict the growth of the market. Advances, for example, mass spectrometry and polymerase chain response can be utilized as substitutes to biochips. Mass spectrometry is utilized to decide and investigate spectra of various particles present in the example of any material. Polymerase chain response is the technique for intensification of a solitary or a couple of duplicates of DNA got from any source.
Key Takeaways:
In terms of volume, the microarrays segment dominated the US biochip products and services industry in 2019, accounting for 57.5 percent of the market. The market is expected to expand due to increased research and development as well as an increase in cancer prevalence.
Market Trends:
A mix of biochips with cutting-edge sequencing. Biochip stages for single-cell or uncommon particle examinations by cutting-edge sequencing encourage advantageous readiness of nucleic acids from organic frameworks.
Advancement in customized medication is expected to support the development of the market. Biochips alongside cutting-edge sequencing can be utilized in drug evaluating for customized medication.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/3899
Competitive Landscape:
Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd., Surfix B.V., and AYOXXA Biosystems GmbH are among the major players in the US biochip products and services industry.
Key Developments:
In April 2019, Qurin Diagnostics B.V. and Lionix International B.V. acquired Surfix B.V., a supplier of custom-made nanocoatings
In January 2019, AYOXXA Biosystems GmbH has signed a research agreement with one of the world’s leading pharmaceutical companies (details were not disclosed) to develop a series of low-volume, high-sensitivity multiplex protein assays for the validation of protein biomarkers in the field of ophthalmology.
Reasons to Purchase this Report
• Current and future of global U.S. Biochip Product & Services market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Application
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Technological Advancements
- Regulatory Scenario
- Mergers and Acquisitions
- Market Dynamics
- U.S. Biochip Products and Services Market, By Type, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Microarrays
- Reagents & other Consumables
- Others
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- U.S. Biochip Products and Services Market, By Application, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Microarrays
- Reagents & other Consumables
- Others
- Life Science Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- IVD Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Competitive Landscape
- Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Agilent Technologies
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Affymetrix Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Beckman Coulter, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Illumina Incorporated
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Life Technologies Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Randox Laboratories Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Surfix B.V
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AYOXXA Biosystems GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott Laboratories
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837